KR101833422B1 - Antioxidative or antiobesitic composition comprising extract of Alnus firma - Google Patents
Antioxidative or antiobesitic composition comprising extract of Alnus firma Download PDFInfo
- Publication number
- KR101833422B1 KR101833422B1 KR1020150162950A KR20150162950A KR101833422B1 KR 101833422 B1 KR101833422 B1 KR 101833422B1 KR 1020150162950 A KR1020150162950 A KR 1020150162950A KR 20150162950 A KR20150162950 A KR 20150162950A KR 101833422 B1 KR101833422 B1 KR 101833422B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- mulberry
- total
- obesity
- content
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 81
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 230000003078 antioxidant effect Effects 0.000 title abstract description 27
- 241001564285 Alnus firma Species 0.000 title 1
- 230000036541 health Effects 0.000 claims abstract description 15
- 230000003579 anti-obesity Effects 0.000 claims abstract description 14
- 235000013376 functional food Nutrition 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 11
- 229930003935 flavonoid Natural products 0.000 claims description 10
- 235000017173 flavonoids Nutrition 0.000 claims description 10
- 150000002215 flavonoids Chemical class 0.000 claims description 10
- 235000013824 polyphenols Nutrition 0.000 claims description 10
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 9
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims description 8
- 241000219496 Alnus Species 0.000 claims description 8
- 229920001991 Proanthocyanidin Polymers 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 230000003013 cytotoxicity Effects 0.000 claims description 8
- 231100000135 cytotoxicity Toxicity 0.000 claims description 8
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 238000009825 accumulation Methods 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 4
- 239000000883 anti-obesity agent Substances 0.000 claims 1
- 229940125710 antiobesity agent Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 240000000249 Morus alba Species 0.000 abstract description 45
- 235000008708 Morus alba Nutrition 0.000 abstract description 45
- 239000003963 antioxidant agent Substances 0.000 abstract description 20
- 208000008589 Obesity Diseases 0.000 abstract description 13
- 235000020824 obesity Nutrition 0.000 abstract description 13
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 8
- 208000030159 metabolic disease Diseases 0.000 abstract description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 239000000523 sample Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 18
- 238000002835 absorbance Methods 0.000 description 18
- 235000006708 antioxidants Nutrition 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 241000272525 Anas platyrhynchos Species 0.000 description 15
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 13
- 238000009472 formulation Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 8
- 239000011668 ascorbic acid Substances 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 241000272522 Anas Species 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 210000001789 adipocyte Anatomy 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 6
- -1 lipid peroxides Chemical class 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 6
- 239000003642 reactive oxygen metabolite Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 235000014347 soups Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000012496 blank sample Substances 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- 240000000643 Alnus japonica Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000006851 antioxidant defense Effects 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000000229 preadipocyte Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- IMOYOUMVYICGCA-UHFFFAOYSA-N 2-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C=C1C(C)(C)C IMOYOUMVYICGCA-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-QDBORUFSSA-N AAPH Chemical compound Cl.Cl.NC(=N)C(C)(C)\N=N\C(C)(C)C(N)=N LXEKPEMOWBOYRF-QDBORUFSSA-N 0.000 description 1
- 241000251557 Ascidiacea Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- WUUVTZUSGKYHIL-UHFFFAOYSA-N COC(C([N+]1=C(C(NC2=CC=CC=C2)=O)N=NN1)=C1)=CC([N+]([O-])=O)=C1S([O-])(=O)=O Chemical compound COC(C([N+]1=C(C(NC2=CC=CC=C2)=O)N=NN1)=C1)=CC([N+]([O-])=O)=C1S([O-])(=O)=O WUUVTZUSGKYHIL-UHFFFAOYSA-N 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241001502127 Mullus barbatus Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- BQZFDPZOAJMUIU-UHFFFAOYSA-N iron(3+);hexacyanide Chemical compound [Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] BQZFDPZOAJMUIU-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000024977 response to activity Effects 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000003817 vacuum liquid chromatography Methods 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020782 vitamin E status Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/30—Meat extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2116—Flavonoids, isoflavones
- A23V2250/21166—Proanthocyanidins, grape seed extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2132—Other phenolic compounds, polyphenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a composition for antioxidant or anti-obesity containing a mulberry extract, wherein the pharmaceutical composition or the health functional food containing the mulberry extract comprises a composition for treating metabolic diseases such as obesity, Can be easily used as a health functional food.
Description
The present invention relates to a composition for antioxidant or anti-obesity containing a mulberry extract.
In recent years, the population of obesity has been rapidly increasing due to improvements in living standards due to economic development, lack of exercise due to busy living environment, and excessive intake of nutrition. Obesity is a condition in which energy is excessively accumulated in the body due to unbalanced energy intake and consumption, resulting in an abnormally increased adipose tissue. The World Health Organization (WHO) considers Oriental BMI (body mass index) 23-25 as overweight, 25-30 obese, and over 30 as high obesity. The causes of obesity include environmental factors such as high fat, high calorie diet, lack of exercise due to busy social environment, endocrine abnormality, and genetic factors. Of these, about 50 to 70% of obesity is due to environmental factors And the rest is known to be caused by genetic factors. According to statistics from the World Health Organization (WHO), the incidence of obesity is estimated to be around 4 billion, or about 6% of the world's population, estimated to be obesity by 2008, and by 2015 to more than 700 million . Especially in OECD countries, the adult obesity population is increasing year by year, and in the United States, one in three is obese. In Korea, the obesity population is increasing rapidly due to changes in the living environment, and the Korean adult obesity population with a body mass index (BMI) of 25 or more is increased by 40 million every year. As of 2005, 3 out of 10 were obese. According to data from the CDC, the obesity population in 1995 was 26.3% of the total population, but in 2001 it increased to 30.6% of the total population and to 31.5% of the total population in 2005, showing a steady increase trend.
Antioxidation refers to the prevention of many oxidizing reactions in the body. When lipids or lipid proteins present as biological membranes or lipoproteins are attacked by free radicals generated in the body to form various kinds of peroxides, the structures and functions of the surrounding biomolecules are changed, It causes chronic diseases. There are many antioxidant defense mechanisms in the body that can neutralize these free radicals and protect the body. In vivo, free radicals are converted to H 2 O 2 by using superoxide dismutase (SOD), an antioxidant enzyme in liver and red blood cells, as a means of protecting the body from these harmful radicals. The H 2 O 2 produced in this case can be used to remove the antioxidant enzymes such as catalase (CAT), glutathione-peroxidase (GSH-px) and vitamin E and glutathione, (Tiidus PM et al., Sported Med., 20, pp. 12-13, 1995; Britton, C., et al., Physio. Rev., 59, pp. 527-605, 1979; Ishinaga M et al., J. Nutr. Sci. Vitaminol., 40, pp. 557-567, 1994). However, when such an antioxidant defense system declines to such an extent that free radical formation can not be controlled, excessive excess free radicals generated in the body cause an increase in lipid peroxides and protein oxides, an increase in DNA damage, (Kumar CT et al., Mol. Cell Biochem., 111, pp. 109-115, 1992). Therefore, many synthetic or natural antioxidants have been developed for the reduction of oxidative stress, but synthetic antioxidants have been reported to be vulnerable to safety (Ito N et al., J. Natl. Cancer Inst., 70, pp 343-349, 1983). In recent years, the use of carotenoids, flavonoids, and polyphenols, which are antioxidant substances such as vitamins A, C, and E, which are present in various herbal medicines and edible plant extracts, We are working hard.
The Alnus sp. Plant belongs to the Betulaceae family. There are about 30 species in the northern part of South America, and more than 17 species are known to be native to Korea such as ducks, thorns, mulberry, mulberry, have. The bark of a mulberry tree is called "red mullet" in the private and the oriental medicine. It is known that the medicinal effects known to date are effective for relieving hangover by treatment of cyanosis, strengthening action, non-hemorrhage, diarrhea, trauma hemorrhage and other folk remedies. Especially, it grows well in dry land because it grows well in the dry land. It is easy to cultivate because it grows rapidly in the dry land. It is a species that is mainly used for greening projects in Korea and the greenery project in the mountain region of Korea. .
The inventors of the present invention studied the various physiological activities of Alnus firm extract, and found that the extract of Sambang Duck had antioxidant or anti-obesity effects, thus completing the present invention.
As a prior art for the present invention, Korean Patent Laid-Open No. 10-2014-0100117, which discloses an extract of Alnus japonica and its inhibitory effect on lipid differentiation, Korean Patent No. 10-1062003, The antioxidative activity and the structural correlation activity of the compound isolated from the mulberry tree were disclosed in the thesis of Chungbuk National University, which started the antioxidant activity of the mulberry tree extract, the chemical component of the mulberry and the inhibitory activity of the adipocyte formation, Journal of Applied Physics, Vol. 34, No. 2.
It is an object of the present invention to provide a composition for antioxidant or anti-obesity containing a mulberry extract.
The present invention relates to an antioxidant or anti-obesity composition containing an Alnus firm extract.
The polyphenol content was 400 to 500 mg GAE / g, the total flavonoid content was 50 to 100 mg QE / g, the total proanthocyanidin content was 100 To 200 mg CE / g.
The duck duck extract can be extracted with water, C1-C4 alcohol or a mixed solution thereof as a solvent.
The present invention relates to a health functional food for antioxidant or anti-obesity containing an extract of Alnus firm .
Hereinafter, the present invention will be described in detail.
The present invention relates to an antioxidant or anti-obesity composition containing an Alnus firm extract. The solid content of the mulberry extract may preferably be 0.001 to 100 占 퐂 / ml, more preferably 1 to 100 占 퐂 / ml, and most preferably 25 to 100 占 퐂 / ml. The total polyphenol content of the mulberry extract is preferably 300-600 mg GAE / g, more preferably 400-500 mg GAE / g, most preferably 436.26 3.30 mg GAE / g, and the total flavonoid content preferably Preferably 10 to 200 mg QE / g, more preferably 50 to 100 mg QE / g, most preferably 73.82 ± 0.54 mg QE / g, and the total proanthocyanidin content is preferably 10 to 300 mg CE / g, more preferably 100-200 mg CE / g, most preferably 149.25 6.06 mg CE / g.
The mulberry duck extract may be extracted with water, a C1-C4 alcohol, or a mixed solution thereof as a solvent. The C1-C4 alcohol may be extracted from methanol, ethanol, propanol, isopropanol, butanol and isobutanol Can be selected. The solvent is preferably a 50 to 90% (v / v) aqueous solution of a C1 to C4 alcohol, more preferably a 50 to 90% (v / v) aqueous solution of ethanol, most preferably a 70% v) aqueous solution.
The water, the C1-C4 alcohol, or the mixed solution thereof used in the preparation of the mulberry duck extract may be used in a volume of 1 to 40 times (1 to 40 liters per 1 kg) based on the weight of the mulberry used, preferably 5 to 40 times The volume can be used. The extraction conditions of the mulberry duck extract may be 1 to 48 hours at 20 to 100 ° C. The above process can be repeated 1 to 4 times. However, the extraction conditions are not limited thereto. As the extraction apparatus, a conventional extraction apparatus, an ultrasonic pulverization extractor, or a fractionator may be used. The thus prepared mulberry duck extract can be removed by hot air drying, vacuum drying or freeze drying. In addition, the mulberry duck extract can be purified by using column chromatography.
The mulberry extract may be isolated or isolated by known methods used for the separation and extraction of plant components, such as extraction with an organic solvent (alcohol, ether, acetone, etc.), partition with hexane and water, And may be fractionated or purified by a suitable combination method.
The chromatography can be carried out using silica gel column chromatography, LH-20 column chromatography, ion exchange resin chromatography, medium pressure liquid chromatography chromatography, thin layer chromatography (TLC), silica gel vacuum liquid chromatography, and high performance liquid chromatography.
In the present invention, it is possible to use any part such as a leaf, a branch, a stem, a bark, a woody part, a root, a fruit and the like, preferably a leaf, Leaf extracts have the most antioxidant or anti-obesity effect than the other extracts.
The present invention also provides a pharmaceutical composition for antioxidant or anti-obesity containing a mulberry extract. The mulberry extract may be added to the pharmaceutical composition of the present invention in an amount of 0.001 to 100% by weight.
The pharmaceutical compositions may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols and the like, oral preparations, suppositories and sterilized injection solutions according to conventional methods. Examples of carriers, excipients and diluents that can be contained in the pharmaceutical composition include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient, such as starch, calcium carbonate, sucrose, Lactose, gelatin, and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of the liquid preparation for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
The dosage of the pharmaceutical composition of the present invention will depend on the age, sex, body weight of the subject to be treated, the particular disease or condition to be treated, the severity of the disease or condition, the route of administration and the judgment of the prescriber. Dosage determinations based on these factors are within the level of ordinary skill in the art and generally the dosage ranges from 0.01 mg / kg / day to approximately 2000 mg / kg / day. A more preferable dosage is 1 mg / kg / day to 500 mg / kg / day. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.
The pharmaceutical composition of the present invention can be administered to mammals such as rats, livestock, humans, and the like in various routes. All modes of administration may be expected, for example, by oral, rectal or intravenous, intramuscular, subcutaneous, intra-uterine dural or intracerebral injection. Since the compound of the present invention has little toxicity and side effects, it can be safely used even for long-term administration for preventive purposes.
The present invention also provides a health functional food for antioxidant or anti-obesity, comprising a mulberry extract and a pharmaceutically acceptable food-aid additive. The mulberry extract may be added to the health functional food of the present invention in an amount of 0.001 to 100% by weight. The health functional food of the present invention includes forms such as tablets, capsules, pills, and liquids. Examples of the foods to which the extract of the present invention can be added include various kinds of drinks, meat, sausage, bread, Snacks, noodles, ice cream, dairy products, soups, ionic drinks, beverages, alcoholic beverages, gums, tea and vitamin complexes.
The present invention relates to a composition for antioxidant or anti-obesity containing a mulberry extract, wherein the pharmaceutical composition or the health functional food containing the mulberry extract comprises a composition for treating metabolic diseases such as obesity, Can be easily used as a health functional food.
As a prior art for the present invention, Korean Patent Laid-Open No. 10-2014-0100117, which discloses an extract of Alnus japonica and its inhibitory effect on lipid differentiation, Korean Patent No. 10-1062003, The antioxidative activity and the structural correlation activity of the compound isolated from the mulberry tree were disclosed in the thesis of Chungbuk National University, which started the antioxidant activity of the mulberry tree extract, the chemical component of the mulberry and the inhibitory activity of the adipocyte formation, Journal of Applied Physics, Vol. 34, No. 2. However, the extract of the present invention is more excellent in antiobesity or antioxidant activity than the extracts containing the ants of the preceding documents, including the stem, branches and roots of the ducks. In addition, the present invention extracts only the leaf of the mulberry tree separately, and confirms the concentration of the mulberry leaf extract without cytotoxicity unlike the above-mentioned prior arts. At this concentration, the total polyphenol, the total flavonoid And an appropriate content of total proanthocyanidins, thereby providing the best-bodied four-legged duck extract.
Fig. 1 shows the measurement results of the DPPH radical scavenging activity of the mulberry extract.
Fig. 2 shows the results of measurement of ABTS radical scavenging activity of the mulberry extract.
Fig. 3 shows the measurement results of reducing power of the mulberry extract.
Fig. 4 shows the results of cytotoxicity analysis of the extract of mulberry duck.
Fig. 5 shows the result of confirming the fat accumulation amount of the mulberry extract.
6 shows the result of measuring the ROS scavenging activity of adipocyte extract in adipocytes.
Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, the intention is to provide an exhaustive, complete, and complete disclosure of the principles of the invention to those skilled in the art.
≪ Example 1 > Preparation of Oriental Duck Extract >
100 g of the leaves were extracted from 1000 ml of 70% (v / v) ethanol solution and then extracted at room temperature (25 ° C) for 24 hours. The extraction procedure was repeated three times, and the obtained extracts were all combined. The extract was filtered with a filter paper (Whatman, No.3, Maidstone, Kent, UK), concentrated under reduced pressure using a rotary vacuum concentrator (EYELA, N-3000, Tokyo, Japan) and then lyophilized (Ilshinbiobase Co., Ltd.). , Ltd, Yangju, Korea).
Example 2. Identification of antioxidant activity of extracts of Oriental ducks
Example 2-1. Sample Preparation
The mulberry duck extract obtained in Example 1 was dissolved in a 94% (v / v) ethanol aqueous solution and prepared at each concentration (50, 25, 12.5, 6.25, and 3.125 占 퐂 / ml).
Ascorbic acid and BHA (2,3-butyl-4-hydroxyanisole) were also prepared for each concentration (20, 10, 5, 2.5, 1.25, 0.625 ㎍ / ㎖).
Example 2-2. Measurement of DPPH radical scavenging activity
For the measurement of DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity, 0.1 ml of sample and 0.1 ml of 0.4 mM DPPH solution were mixed and reacted in a dark place for 30 minutes. The absorbance values at 515 nm of a microplate reader (Molecular Devices, Sunnyvale, Calif., USA) were measured. The DPPH radical scavenging activity was calculated using the following equation, and the results are shown in FIG. 1 and Table 1 .
DPPH radical scavenging ability (%) = [(Ac - As) / Ac] x 100
Ac: Absorbance of blank sample, As: Absorbance of sample group
As shown in FIG. 1, the DPPH radical scavenging activity of the extract of Duck Duck was 65% at a concentration of 50 μg / ml. As shown in Table 1, the IC 50 value was 28.06 ㎍ / (IC 50 value of ascorbic acid used as a positive control, 7.61 / / ml, IC 50 value of BHA of 14.66 / / ml).
Examples 2-3. Measurement of ABTS radical scavenging activity
The radical scavenging activity of ABTS (2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) is a measure of antioxidative activity of both fat soluble and water soluble antioxidants. The ABTS radical scavenging activity was measured by mixing 7 mM ABTS solution and 2.45 mM potassium persulfate and reacting at room temperature for 12-16 hours with light blocked to form ABTS cation And 50 μl of the sample and 150 μl of diluted ABTS solution were added and reacted at room temperature for 20 minutes, and the absorbance at 734 nm of the microplate analyzer was measured. The absorbance at 734 nm was adjusted to 0.70 ± 0.02 at 734 nm. The ABTS radical scavenging activity was calculated using the following equation and is shown in FIG. 2 and Table 2.
ABTS radical scavenging ability = [(Ac-As) / Ac] x 100
Ac: Absorbance of blank sample, As: Absorbance of sample group
As shown in FIG. 2, the ABTS radical scavenging activity of the extract of Duckweed was found to be about 90% at the concentration of 50 μg / ml. As shown in Table 2, ABTS It was confirmed that the radical scavenging activity IC 50 was 25.90 μg / ml, that the ABTS radical scavenging activity IC 50 of ascorbic acid as a positive control was 17.56 μg / ml, and that the ABTS radical scavenging activity IC 50 of BHA was 15.53 μg / ml.
Example 2-3. Confirm Reduction Power
In order to confirm the reducing power, the ability of Fe 3 + (ferric-ferricyanide) to be reduced to Fe 2 + (ferrous) is measured. 0.5 ml of sample, 0.5 ml of 0.2 M sodium phosphate buffer and 0.5 ml of 1% potassium ferricyanide were mixed and reacted at 50 ° C for 20 minutes. Then, 0.5 ml of 10% trichloroacetic acid was added thereto and centrifuged at 12,000 rpm for 10 minutes. After centrifugation, 1.0 ml of supernatant and 0.2 ml of 0.1% iron (Ⅲ) chloride were added, reacted at room temperature for 10 minutes, and absorbance was measured at 700 nm on a microplate analyzer. The results are shown in Fig. 3 The reducing power of 25 / / ml of acid was calculated as 100%).
Referring to FIG. 3, it can be seen that the reducing power of the mulberry extract is increased in a concentration-dependent manner.
Examples 2-4. Verify ORAC Acquisition
The ORAC assay is a kind of inhibition method for measuring the degree of free radical damage to fluorescent labels. To perform the ORAC assay, samples are dissolved in 75 mM phosphate buffer (pH 7.4) , 150 μl of 40 nM Fluorescein as a fluorescent substance and 25 μl of 18 mM AAPH (2,2'-azobis (2-methylpropionamidine) dihydrochloride) producing peroxyl radical were added and reacted at 37 ° C for 15 minutes. The fluorescence spectrophotometer was adjusted at 37 ° C, and then measured for 90 minutes at an excitation wavelength of 485 nm and an emission wavelength of 520 nm once every 3 minutes. The results are shown in Table 3 below. If antioxidants are present in the sample, the free radical damage is inhibited in proportion to these concentrations, thus the change (decrease) in fluorescence is suppressed. Trolox (0 ~ 10 μM) was used as the reference material and the area under the curve (AUC) of the standard reagent and the sample was measured. ORAC was expressed as μM TE / ㎎ using a regression curve between standard reagent concentration and AUC.
Referring to Table 3 above, it was confirmed that the extract of Orthodox ducks had a value of 792.01 ± 13.10 μM TE / mg as measured by ORAC (Oxygen radical absorbing capacity).
Examples 2-5. Measurement of NO radical scavenging ability
For the measurement of NO (nitric oxide) radical scavenging ability, 0.5 ml of 1 mM NaNO 2 solution was added to 0.5 ml of the sample, the pH of the reaction solution was adjusted to 1.2 with 0.1 N HCl, and the final volume of the reaction solution was adjusted to 5 ml by adding distilled water. This solution was reacted at 37 ° C for 1 hour. Take 1 ml of the reaction mixture and add 5 ml of 2% acetic acid and 1 ml of Griess reagent (A: B = 1: 1, A: 1% sulfanilic acid in 30% : 1% naphthylamine in 30% acetic acid) was added and mixed well. The mixture was reacted at room temperature for 15 minutes and absorbance was measured at 520 nm. The results are shown in Table 4 below. NO radical scavenging activity was calculated using the following equation.
NO radical scavenging ability = [(Ac - As) / Ac] x 100
Ac: Absorbance of blank sample, As: Absorbance of sample group
As shown in Table 4, the NO radical scavenging ability of the extracts from the mulberry ducks was NO radical scavenging ability at a concentration of 61.31% at 500 μg / ml, 29.24% at 200 μg / ml and 17.20% at 100 μg / ml And ascorbic acid, a positive control, showed 64% of NO radical scavenging activity at 500 ㎍ / ㎖, indicating that Sambang Duck Extract had similar activity to the positive control.
Examples 2-6. Total polyphenol, total flavonoid, and total proanthocyanidin content
Total phenolic contents were measured using Folin-Ciocalteu. To 500 ml of each sample, 1.25 ml of 12.5% (w / v) sodium carbonate solution and 250 μl of 1.0 M Folin-Ciocalteu's reagent were mixed and allowed to stand in a dark place for 40 minutes and the absorbance was measured at 750 nm on a microplate analyzer. Gallic acid was used as a standard and expressed as mg GAE / g sample.
The total flavonoids contents 0.5 ml of 2% (w / v) aluminum chloride was added to 0.5 ml of each sample and reacted at room temperature for 60 minutes. Absorbance was measured at 420 nm on a microplate analyzer. Quercetin was used as a standard and ㎎ QE / g respectively.
Total anthocyanin contents were measured using vanillin-hydrochloric acid (V-HCl). 0.5 mg of each sample was dissolved in 5 ml of methanol, and then 3 ml of 4% (w / v) vanillin solution was added thereto to vigorously agitate. After that, 1.5 ml of Concentrated hydrochloric acid was added to the reaction solution, reacted at room temperature for 15 minutes, and the absorbance was measured at 490 nm in a microplate analyzer. At this time, catechin was used as a reference material and expressed in ㎍ CE / g sample.
The results of each experiment are shown in Table 5 below.
As shown in Table 5, total polyphenol, total flavonoid and total proanthocyanidin content of mulberry duck extract were 436.26 ± 3.30 mg GAE / g and 73.82 ± 0.54 mg QE / g, respectively, , And the total proanthocyanidin was 149.25 ± 6.06 mg CE / g, indicating that the antioxidant ability of the extract of the oriental ducks was excellent.
<Example 3> Confirmation of anti-obesity activity of extract of Oriental ducks>
Example 3-1. Preparation of sample
As the samples used in the experiment, the duckberry extract obtained in Example 1 was used at a concentration of 25 μg / ml, 50 μg / ml and 100 μg / ml using 100% DMSO (dimethyl sulfoxide).
Example 3-2. 3T3-L1 cell culture
3T3-L1 cells were purchased from ATCC and cultured in high-glucose DMEM (Dulbecco's modified Eagle's medium) in the presence of 10% BS (bovine serum) and 1% penicillin / streptomycin (P / S) at 37 ° C in a 5% CO 2 incubator . When the 3T3-L1 cells in the preadipocyte state are filled to 100% in the cell culture dish, a high concentration of 10% FBS (fetal bovine serum) and 1% P / S are added for differentiation into adipocytes Glucose DMEM was used and 0.5 mM Isobutylmethylxanthine (IBMX), 1 μM Dexamethasone (DEX) and 1 μg / ㎖ insulin were added for 48 hours. Cells were cultured and tested in a 96-well plate and a 24-well plate by dividing cells according to the purpose of the experiment.
Example 3-3. Evaluation of cytotoxicity using XTT assays
The cytotoxicity of 3T3-L1 cells was assessed using the XTT assay (2-methoxy-4-nitro-5-sulfophenyl) -2H-tetrazolium-5-carboxanilide innersalt assay kit Respectively. XTT and PMS were added to the cells to increase the bioreduction by adding PMS (phenazine methosulfate), which serves as an Election coupling agent to XTT, and then the Tetrazolium ring of XTT by mitochondrial dehydrogenase of living cells was decomposed to form Formazan crystal Formazan crystals are dissolved in aqueous solution and become yellow. This yellow was measured by ELISA (VersaMax ELISA Microplate Reader, Molecular Devices, Sunnyvale, USA) and used for cytotoxicity evaluation. For this purpose, 3T3-L1 preadipocyte cells were plated in 96-well plates at a concentration of 1 × 10 6 on the day before the experiment and cultured for 24 hours. The concentrations of the extracts of Oriental mulberry were 25 ㎍ / ㎖, 50 ㎍ / ㎖ and 100 ㎍ / ㎖, respectively, and cultured in a cell incubator for 24 hours. Then, 1 ㎖ of XTT and 20 ㎕ of PMS reagent were mixed, and 20% of the media volume was added. After reacting for 4 hours in a cell incubator, absorbance at 450 nm and 690 nm was measured using a spectrophotometer And the result is shown in FIG.
4, the effect on the survival rate of 3T3-L1 cells was measured by the XTT assay using a concentration of 25 μg / ml, 50 μg / ml and 100 μg / ml, respectively, , And did not show cytotoxicity up to 100 μg / ml of the duck duck extract.
Example 3-4. Estimation of fat accumulation inhibitory effect by oil red O staining
To measure the amount of fat accumulation in 3T3-L1 cells according to the differentiation process using Oil red O staining, each sample was treated to remove the culture of 3T3-L1 cells differentiated for 8 days in a 24-well plate Then, 0.5 ml of a 10% formalin solution was added, and the mixture was allowed to stand at room temperature for 5 minutes. 3T3-L1 cells differentiated with the same amount of formalin solution were left at room temperature for more than 1 hour, formalin was removed, and cells were washed with 0.5 ml of 60% isopropyl alcohol solution to completely dry the cells. The fully dried cells were stained with a pre-prepared working solution (Oil Red O: DDW = 6: 4), and the cells were washed 4 times with distilled water It was completely dried. The oily red O bound to the lipid components accumulated in the cells was eluted with a 100% isopropyl alcohol solution and absorbance was measured at 490 nm using a spectrophotometer. At this time, the degree of differentiation of 3T3-L1 cells was compared using 5 mM NAC (N-acetyl-L-cysteine) as a positive control, and the results are shown in FIG.
FIG. 5 shows that the fat accumulation amount was significantly decreased in the concentration-dependent manner on the mulberry extract (AF), and the mulberry dug extract was found to be effective in inhibiting fat accumulation .
Examples 3-5. Evaluation of ROS abatement efficacy using NBT assay
To measure the amount of reactive oxygen species (ROS) produced by the differentiation process using NBT assay (Nitroblue tetrazolium assay), the culture medium of 3T3-L1 cells cultured and differentiated for 8 days in 24 well plate was removed After washing twice with sterile PBS (phosphate-buffered saline, pH 7.4), 0.2 ml of 0.2% (w / v) NBT (nitroblue tetrazolium) solution was added and incubated in a CO 2 incubator for 90 minutes. After the staining, the plate was rinsed twice with distilled water and dried. DMSO (the ROS accumulated in the cells reacted with the NBT solution to produce dark blue formazan, which was eluted from the cells to measure the absorbance) and 1 N potassium hydroxide : 3 (v: v). The same amount of distilled water was added thereto, and the absorbance was measured at 570 nm using a spectrophotometer. The results are shown in FIG.
Referring to FIG. 6, it was shown that the ROS content was significantly decreased in adipocytes treated with mulberry extract (AF) in a concentration-dependent manner (group without con-extract in FIG. 6).
≪ Formulation Example 1 >
Formulation Example 1-1. Manufacture of tablets
200 g of the extract of the present invention was mixed with 175.9 g of lactose, 180 g of potato starch and 32 g of colloidal silicic acid. To this mixture was added a 10% gelatin solution, which was pulverized and passed through a 14-mesh sieve. This was dried, and a mixture obtained by adding 160 g of potato starch, 50 g of talc and 5 g of magnesium stearate was made into tablets.
Formulation Example 1-2. Injection preparation
1 g of the mulberry extract of the present invention, 0.6 g of sodium chloride and 0.1 g of ascorbic acid were dissolved in distilled water to make 100 ml. This solution was placed in a bottle and sterilized by heating at 20 DEG C for 30 minutes.
<Formulation Example 2: Food Preparation>
Formulation Example 2-1. Manufacture of cooking seasonings
The safflower extract of the present invention was added to the cooking seasoning at 1 wt% to prepare a cooking sauce for health promotion.
Formulation Example 2-2. Manufacture of flour food products
The bread of the present invention was added to the flour at 0.1 wt%, and bread, cake, cookies, crackers and noodles were prepared to prepare a food for health promotion.
Preparation Example 2-3. Manufacture of soups and gravies
The soup duck extract of the present invention was added to soup and juice at 0.1 wt% to prepare health promotion soup and juice.
Formulation Example 2-4. Manufacture of dairy products
Dawberry extract of the present invention was added to milk in an amount of 0.1% by weight, and various dairy products such as butter and ice cream were prepared using the milk.
Formulation Example 2-5. Vegetable juice manufacturing
The vegetable juice for health promotion was prepared by adding 0.5 g of the duckberry extract of the present invention to 1,000 ml of tomato juice or carrot juice.
Formulation Example 2-6. Manufacture of fruit juice
Healthy fruit juice was prepared by adding 0.1 g of the extract of Quercus mongolica of the present invention to 1,000 ml of apple juice or grape juice.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150162950A KR101833422B1 (en) | 2015-11-20 | 2015-11-20 | Antioxidative or antiobesitic composition comprising extract of Alnus firma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150162950A KR101833422B1 (en) | 2015-11-20 | 2015-11-20 | Antioxidative or antiobesitic composition comprising extract of Alnus firma |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170059101A KR20170059101A (en) | 2017-05-30 |
KR101833422B1 true KR101833422B1 (en) | 2018-02-28 |
Family
ID=59052834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150162950A KR101833422B1 (en) | 2015-11-20 | 2015-11-20 | Antioxidative or antiobesitic composition comprising extract of Alnus firma |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101833422B1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100668172B1 (en) * | 2005-06-07 | 2007-01-11 | 한국생명공학연구원 | Composition for the prevention and the treatment of obesity and type 2 diabetes comprising the extract of Alnus hirsuta or betulinic acid |
KR101062003B1 (en) * | 2008-07-02 | 2011-09-05 | 창원대학교 산학협력단 | Composition for the prevention and the treament of diabetes containing Alnus firma Sieb. et Zucc extracts or compounds separated therefrom as an effective ingredient |
-
2015
- 2015-11-20 KR KR1020150162950A patent/KR101833422B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100668172B1 (en) * | 2005-06-07 | 2007-01-11 | 한국생명공학연구원 | Composition for the prevention and the treatment of obesity and type 2 diabetes comprising the extract of Alnus hirsuta or betulinic acid |
KR101062003B1 (en) * | 2008-07-02 | 2011-09-05 | 창원대학교 산학협력단 | Composition for the prevention and the treament of diabetes containing Alnus firma Sieb. et Zucc extracts or compounds separated therefrom as an effective ingredient |
Also Published As
Publication number | Publication date |
---|---|
KR20170059101A (en) | 2017-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kreft | Buckwheat phenolic metabolites in health and disease | |
Murray et al. | An emerging trend in functional foods for the prevention of cardiovascular disease and diabetes: Marine algal polyphenols | |
Madrigal-Santillán et al. | Review of natural products with hepatoprotective effects | |
da Fonseca Machado et al. | Polyphenols from food by-products: An alternative or complementary therapy to IBD conventional treatments | |
Abbas et al. | An overview and update on the chemical composition and potential health benefits of Opuntia ficus‐indica (L.) Miller | |
Zendehbad et al. | Flavonoids and phenolic content in wheat grass plant (Triticum aestivum) | |
Mauray et al. | Atheroprotective effects of bilberry extracts in apo E-deficient mice | |
Jiang et al. | A review on the gastrointestinal protective effects of tropical fruit polyphenols | |
Mah | Chalcones in diets | |
Ouahhoud et al. | Antidiabetic effect of hydroethanolic extract of Crocus sativus stigmas, tepals and leaves in streptozotocin-induced diabetic rats | |
Murray et al. | Phlorotannins and macroalgal polyphenols: Potential as functional food ingredients and role in health promotion | |
Isla et al. | Flower beverages of native medicinal plants from Argentina (Acacia caven, Geoffroea decorticans and Larrea divaricata) as antioxidant and anti-inflammatory | |
KR101944014B1 (en) | Antiobesitic composition comprising extract of Rhododendron mucronulatum | |
Che Sulaiman et al. | Murdannia loriformis: A review of ethnomedicinal uses, phytochemistry, pharmacology, contemporary application, and toxicology | |
Omoregie et al. | In vitro antioxidant activity and the effect of methanolic extracts of some local plants on nutritionally stressed rats | |
Benmeziane-Derradji et al. | Antioxidant activities and beneficial health effects of some dried fruits commonly consumed in Algeria: A review | |
KR20160141463A (en) | Anti-oxidation and anti-inflammatory composition comprising the extract of aralia continentalis | |
KR101182765B1 (en) | Cosmetic Composition Comprising Citrus sunkiSanmul S.Marcov And Zingiber Officinale Roscoe Mixed Extract Having Anti-oxidation and Anti-aging Effects And Manufacturing Method Thereof | |
KR101833422B1 (en) | Antioxidative or antiobesitic composition comprising extract of Alnus firma | |
KR101636608B1 (en) | Composition for antioxidation comprising the seed extract of cornus officinalis | |
KR101871318B1 (en) | Antiobesitic composition comprising extract of Castanea crenata | |
KR20110130857A (en) | Functional composition having anti-oxidative function, anti-allergic, improvement and prevention effect of atopic dermatitis, and method for manufacturing the same, and a healthful food having the same | |
Abir et al. | Phytochemical, Nutritional and Pharmacological Potentialities of Amaranthus spinosus Linn.: A review | |
KR102214014B1 (en) | Antioxidant or anticancer composition comprising extract of Osmanthus heterophylla leaf | |
Blando et al. | Opuntia, ficus‐indica [L.] Mill. and Other Species: Source of Bioactives and Their Molecular Mechanisms of Action to Promote Human Health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |